General Mills is buying its fifth pet-food business. Here’s why it could fetch more growth.
From an estimated $150 billion of spending in 2024, the category is expected to mushroom up to roughly $200 billion by 2030, ...
Business Insider19h
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved ...
Hosted on MSN20h
The FDA wants these cold medicines off the shelves. Should Canada follow?
Many may now wonder whether Canada could be pressured to do the same ... when medicines with an older ingredient — ...